摘要
背景:自19世纪以来,已经描述了双相情感障碍(BD)背景下的强迫症(OCD)症状。有趣的是,最近的一些流行病学和家庭研究证实了上述精神病综合征之间存在相关重叠。 目的:本文的目的是回顾OCD-BD合并症的临床特征和治疗意义。 讨论:在过去的二十年中,鉴于其相关的病理学和治疗意义,OCD和BD之间的频繁关联已经引起了越来越多的关注。通常患有OCD-BD合并症的患者表现出特殊的临床过程,其特征在于伴随的抑郁发作和发作过程的数量较多。在这些情况下,抗抑郁药治疗更容易引起轻度躁狂或躁狂转换,而情绪稳定剂可显着改善整体临床表现。此外,OCD-BD患者经常与许多其他精神疾病共病,特别是焦虑症,社交恐怖症和不同的物质滥用,例如酒精,尼古丁,咖啡因和镇静剂。 结论:BD-OCD合并症需要进一步研究,以便为患者提供更准确的临床诊断和更有针对性的治疗方法提供更有力的证据。
关键词: 强迫症,双相情感障碍,精神病合并症,抗抑郁药,情绪稳定剂,非典型抗精神病药
Current Medicinal Chemistry
Title:Obsessive-compulsive Disorder with Comorbid Bipolar Disorders: Clinical Features and Treatment Implications
Volume: 25 Issue: 41
关键词: 强迫症,双相情感障碍,精神病合并症,抗抑郁药,情绪稳定剂,非典型抗精神病药
摘要: Background: Obsessive-compulsive disorder (OCD) symptoms within the context of a bipolar disorder (BD) have been described since the 19th century. Interestingly, the existence of a relevant overlap between the aforementioned psychiatric syndromes has been confirmed by a number of recent epidemiological and family studies.
Aims: The aim of the present paper is to review the clinical features and the therapeutic implications of the OCD-BD comorbidity.
Discussion: In the last two decades, the frequent association between OCD and BD has been earning a growing interest given its relevant nosological and therapeutic implications. Usually patients suffering from OCD-BD comorbidity show a peculiar clinical course, characterized by a larger number of concomitant depressive episodes and episodic course. In these cases, the treatment with antidepressants is more likely to elicit hypomanic or manic switches, while mood stabilizers significantly improve the overall clinical picture. Moreover, OCD-BD patients are frequently comorbid with a number of other psychiatric disorders, in particular anxiety disorders, social phobia, and different substance abuses, such as alcohol, nicotine, caffeine and sedatives.
Conclusions: BD-OCD comorbidity needs further investigations in order to provide more solid evidences to give patients a more precise clinical diagnosis and a more targeted therapeutic approach.
Export Options
About this article
Cite this article as:
Obsessive-compulsive Disorder with Comorbid Bipolar Disorders: Clinical Features and Treatment Implications, Current Medicinal Chemistry 2018; 25 (41) . https://dx.doi.org/10.2174/0929867324666171108145127
DOI https://dx.doi.org/10.2174/0929867324666171108145127 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
EDITORIAL (Natural Products for Treatment of Alzheimer's Disease and Related Diseases: Understanding their Mechanism of Action)
Current Neuropharmacology Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis
Current Medicinal Chemistry Opioid and Cannabinoid System in Food Intake
Current Pharmaceutical Design Medicinal Plants: A Complementary and Alternative Antidepressant Therapy
Current Pharmaceutical Design Use of Natural Compounds as a Potential Therapeutic Agent Against COVID-19
Current Pharmaceutical Design Transcranial Magnetic Stimulation on Rodent Models
CNS & Neurological Disorders - Drug Targets The Use of Iontophoresis in the Administration of Nicotine and New Non-Nicotine Drugs through the Skin for Smoking Cessation
Current Drug Discovery Technologies Autophagy to the Rescue
Current Neurovascular Research Synthesis of Chiral 3-Methyl- and 3-Methyl-N-propargyl-1,2,3,4- tetrahydroisoquinoline and Prevention of MPP+-Induced Cytotoxicity
Medicinal Chemistry Recent Advances in Medicinal Chemistry of Sulfonamides. Rational Design as Anti-Tumoral, Anti-Bacterial and Anti-Inflammatory Agents
Mini-Reviews in Medicinal Chemistry Glioma: Tryptophan Catabolite and Melatoninergic Pathways Link microRNA, 14-3- 3, Chromosome 4q35, Epigenetic Processes and other Glioma Biochemical Changes
Current Pharmaceutical Design Naphthalene Toxicity in Clinical Practice
Current Drug Metabolism Maternal Nutrient Restriction is not Equivalent to Maternal Biological Stress
Current Drug Targets Polypharmacology in a Single Drug: Multitarget Drugs
Current Medicinal Chemistry Neurotrophin Receptor Signaling as a Therapeutic Target for Huntington's Disease
CNS & Neurological Disorders - Drug Targets Preface [Hot topic: Autoimmunity (Executive Editors: D. Stahl and W. Sibrowski)]
Current Pharmaceutical Design Structural and Functional Characterization of the Proteins Responsible for N<sup>6</sup>-Methyladenosine Modification and Recognition
Current Protein & Peptide Science Editorial (Thematic Issue: Pharmacologic Strategies with Afterload Reduction in Low Cardiac Output Syndrome After Pediatric Cardiac Surgery)
Current Vascular Pharmacology Heart Failure in North America
Current Cardiology Reviews Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4
CNS & Neurological Disorders - Drug Targets